4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001048477-24-000112
EVP, Chief Legal Officer sold 40,850 shares at an average $74.51 ($3,043,802)
- EVP, Chief Legal Officer acquired 40,850 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Davis George Eric · EVP, Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,850 | $63.10 | $2,577,635 | 97,007 | D |
| 2024-05-28 | Sale : show line 2 in the form 10b5-1 | −38,071 | $74.46 | $2,834,576 | 58,936 | D |
| 2024-05-28 | Sale : show line 3 in the form 10b5-1 | −2,779 | $75.29 | $209,225 | 56,157 | D |
| Open-market sales · 40,850 sh · avg $74.51 · $3,043,802 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-28 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy Common Stock) | −40,850 | 0 | D |
Loading xslF345X05/wk-form4_1717107477.xml…